Sign In

Amy Isaacson

US Study Manager - Immuno-Oncology at AstraZeneca

Professional Background

Amy Isaacson is an accomplished professional in the field of clinical research, specializing in immuno-oncology. With a solid foundation in both psychology and social work, Amy has built an impressive career that merges her academic background with practical, impactful applications in the medical field. Currently, she serves as the US Study Manager for Immuno-Oncology at AstraZeneca, where she excelently manages clinical studies, ensuring their successful execution and contributing to advancements in cancer treatment.

Prior to her role at AstraZeneca, Amy exhibited her versatility and dedication at Synexus Clinical Research Ltd, where she held two key positions. Initially, she worked as a Site Manager for the Papillion, NE site, and subsequently advanced to the District Director for the Nebraska/Iowa region. In these roles, Amy was known for her leadership skills and ability to foster collaborative environments, which are crucial for managing research operations effectively.

Amy's clinical research journey began as a Clinical Research Coordinator at Stanford University School of Medicine, where she contributed significantly to oncology studies. Her time there was marked by her roles both in Breast Oncology and broader Oncology research, showcasing her ability to adapt and thrive in high-pressure environments. Moreover, her early experience at NCIRE - The Veterans Health Research Institute provided her with valuable insights into the importance of psychiatric research, a field that complements her educational background in psychology.

Her journey through clinical research includes diverse responsibilities that have strengthened her expertise in managing complex studies. She began as a Clinical Research Coordinator for Phase I trials at PAREXEL, which laid a solid groundwork for her future roles in coordinating and managing various clinical investigations.

Education and Achievements

Amy Isaacson’s academic qualifications are both broad and deep, reflecting her commitment to understanding human behavior and social systems. She earned a Bachelor of Arts in Psychology from Cornell University, an institution renowned for its rigorous academic programs. This foundation in psychological principles equips her with a unique skill set that enhances her effectiveness in clinical settings, particularly in understanding patient needs and the intricacies of research design.

Furthering her education, Amy obtained a Master of Social Work (MSW) from Portland State University. This advanced degree has not only enhanced her professional qualifications but has also imbued her with a profound understanding of social dynamics and ethics in healthcare. The synthesis of her psychology and social work education prepares her to engage empathetically with diverse populations within her clinical research roles.

In addition to her impressive educational background, Amy's career is characterized by several notable achievements. Throughout her time at Stanford University, she contributed to pivotal oncology clinical trials, influencing treatment avenues for patients battling cancer. Her role at AstraZeneca positions her at the forefront of cancer research, where she plays a significant part in pioneering novel therapies through immuno-oncology.

Achievements

  • Leadership in Clinical Research: As District Director for Nebraska/Iowa at Synexus Clinical Research, Amy demonstrated exemplary leadership by overseeing clinical trials that contributed to significant advancements in patient care and treatment strategies.
  • Innovative Management: At AstraZeneca, Amy's role as US Study Manager exemplifies her ability to manage large-scale studies with precision and dedication, ensuring that clinical trials meet regulatory, ethical, and scientific standards while striving to improve outcomes for patients.
  • Cross-Disciplinary Expertise: Amy's background in both psychology and social work, combined with her clinical research experience, provides a holistic approach to patient care and research methodologies. This interdisciplinary strength enables her to analyze and address the complexities of healthcare delivery, particularly in oncology.
  • Commitment to Quality Research: Throughout her varying roles in clinical settings, Amy has maintained a steadfast commitment to quality and ethical research practices, ensuring that all studies are conducted with integrity and a focus on patient welfare.
  • Advocacy for Patient-Centered Care: Given her education in social work, Amy is deeply invested in advocating for patient-centered approaches within clinical research, ensuring that patient voices and experiences contribute to shaping research agendas and practices.

In conclusion, Amy Isaacson's multifaceted educational background and extensive professional experience make her a distinguished figure in the clinical research community. With a career characterized by leadership, innovation, and a commitment to improving patient care, she serves as a model for emerging professionals in the field. Her contributions, particularly in immuno-oncology at AstraZeneca, are helping to chart a path toward more effective cancer treatments, demonstrating the powerful impact that dedicated research can have on public health.

Related Questions

How did Amy Isaacson transition from clinical research at Stanford University to her role as US Study Manager at AstraZeneca?
What specific strategies does Amy Isaacson employ to ensure the successful management of immuno-oncology studies?
How has Amy Isaacson's education in psychology and social work influenced her approach to clinical research?
In what ways has Amy Isaacson contributed to advancements in cancer treatment during her career?
What leadership qualities did Amy Isaacson demonstrate while serving as District Director at Synexus Clinical Research?
A
Add to my network

Location

Portland, Oregon, United States